Index trend and stocks in action November 05, 2018

After a taking breather in the previous trading session, the bulls packed a punch in Friday’s session as the NSE benchmark closed above its important psychological level of 10,550 with a gain of 1.66 per cent. The price action formed a sizeable bullish candle carrying a minor upper shadow, indicating profit-booking at higher levels. As we enter the week of the auspicious festival of Diwali, we expect the index to witness modestly lower opening. Going ahead, the opening upside gap area (10,442-10,458), which was created on November 2, is likely to act as a support area for the index. On the upside, the Friday’s session high of 10,607 is likely to act as an immediate hurdle for the index and a follow-through move above this level may open up for the levels of 10,710-10,765 in the near term. However, the zone of 10,710-10,765 is a crucial resistance area as it is the confluence of swing high registered on October 17, the daily 200-D SMA is placed in this region and the downside gap area created on October 4.  

Strides Pharma Science: The company has announced that  its formulations facility in Bangalore recently underwent a USFDA inspection that ended on November 2, 2018. The inspection was completed successfully with Zero 483 observations.  
  
Dr Reddy’s Laboratories: The company has completed sale of API manufacturing business unit in Jeedimetla, Hyderabad. 
  
Laurus Labs: The company has announced the completion of US FDA inspections of its Unit 6 API intermediate facility in Andhra Pradesh with one observation. 
  
KEC International:  KEC International Ltd. has signed a share purchase agreement with Adani Transmission Ltd for selling its entire stake in KEC Bikaner Sikar Transmission Private Ltd. at an enterprise value of Rs 227.5 crore, subject to regulatory and other approvals. 
  
Linde India:  Linde AG has completed its global merger between Linde AG and Praxair, Inc.